175 related articles for article (PubMed ID: 23678586)
21. Epigenetics of psychoactive drugs.
Boyadjieva N; Varadinova M
J Pharm Pharmacol; 2012 Oct; 64(10):1349-58. PubMed ID: 22943166
[TBL] [Abstract][Full Text] [Related]
22. An epigenetic framework for neurodevelopmental disorders: from pathogenesis to potential therapy.
Millan MJ
Neuropharmacology; 2013 May; 68():2-82. PubMed ID: 23246909
[TBL] [Abstract][Full Text] [Related]
23. Epigenetics of endometriosis.
Guo SW
Mol Hum Reprod; 2009 Oct; 15(10):587-607. PubMed ID: 19651637
[TBL] [Abstract][Full Text] [Related]
24. Epigenetics of Schizophrenia.
Srivastava A; Dada O; Qian J; Al-Chalabi N; Fatemi AB; Gerretsen P; Graff A; De Luca V
Psychiatry Res; 2021 Nov; 305():114218. PubMed ID: 34638051
[TBL] [Abstract][Full Text] [Related]
25. The convergence of neuropsychological testing and clinical ratings of cognitive impairment in patients with schizophrenia.
Harvey PD; Serper MR; White L; Parrella MJ; McGurk SR; Moriarty PJ; Bowie C; Vadhan N; Friedman J; Davis KL
Compr Psychiatry; 2001; 42(4):306-13. PubMed ID: 11458305
[TBL] [Abstract][Full Text] [Related]
26. Methylation status of the reelin promoter region in the brain of schizophrenic patients.
Tochigi M; Iwamoto K; Bundo M; Komori A; Sasaki T; Kato N; Kato T
Biol Psychiatry; 2008 Mar; 63(5):530-3. PubMed ID: 17870056
[TBL] [Abstract][Full Text] [Related]
27. [Epigenetics and cancer].
Xue C; Yu J; Liu H; Chen J
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Oct; 26(5):1133-6. PubMed ID: 19947505
[TBL] [Abstract][Full Text] [Related]
28. Aberrant epigenetic regulation could explain the relationship of paternal age to schizophrenia.
Perrin MC; Brown AS; Malaspina D
Schizophr Bull; 2007 Nov; 33(6):1270-3. PubMed ID: 17712030
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic Basis of Mental Illness.
Nestler EJ; Peña CJ; Kundakovic M; Mitchell A; Akbarian S
Neuroscientist; 2016 Oct; 22(5):447-63. PubMed ID: 26450593
[TBL] [Abstract][Full Text] [Related]
30. Schizophrenia genes, epigenetics and psychoneuroimmunology therapeutics: all make sense now?
Müller N; Dursun SM
J Psychopharmacol; 2011 Jun; 25(6):713-4. PubMed ID: 20194572
[TBL] [Abstract][Full Text] [Related]
31. Epigenetic studies of schizophrenia: progress, predicaments, and promises for the future.
Dempster E; Viana J; Pidsley R; Mill J
Schizophr Bull; 2013 Jan; 39(1):11-6. PubMed ID: 23211398
[TBL] [Abstract][Full Text] [Related]
32. Negative symptoms in schizophrenia: a review.
Mäkinen J; Miettunen J; Isohanni M; Koponen H
Nord J Psychiatry; 2008; 62(5):334-41. PubMed ID: 18752104
[TBL] [Abstract][Full Text] [Related]
33. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
34. Next-generation sequencing technologies for DNA methylation analyses in cancer genomics.
Boerno ST; Grimm C; Lehrach H; Schweiger MR
Epigenomics; 2010 Apr; 2(2):199-207. PubMed ID: 22121870
[TBL] [Abstract][Full Text] [Related]
35. Recent advances in postmortem pathology and neurochemistry in schizophrenia.
Dean B; Boer S; Gibbons A; Money T; Scarr E
Curr Opin Psychiatry; 2009 Mar; 22(2):154-60. PubMed ID: 19553869
[TBL] [Abstract][Full Text] [Related]
36. [How to differentiate schizophrenia from bipolar disorder using cognitive assessment?].
Demily C; Jacquet P; Marie-Cardine M
Encephale; 2009 Apr; 35(2):139-45. PubMed ID: 19393382
[TBL] [Abstract][Full Text] [Related]
37. Preliminary neuropsychological findings in individuals at high genetic risk for schizophrenia.
Bertisch HC; Fava J; Kattan A; DeLisi LE
Early Interv Psychiatry; 2008 Feb; 2(1):45-9. PubMed ID: 21352131
[TBL] [Abstract][Full Text] [Related]
38. [Results and promises of genetics of cognitive impairment in schizophrenia: molecular-genetic approaches].
Alfimova MV; Kondratiev NV; Golimbet VE
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11):137-144. PubMed ID: 28635752
[TBL] [Abstract][Full Text] [Related]
39. Can specific deficits in executive functioning explain the negative symptoms of schizophrenia? A review.
Donohoe G; Robertson IH
Neurocase; 2003 Apr; 9(2):97-108. PubMed ID: 12925934
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic dysregulation in cognitive disorders.
Gräff J; Mansuy IM
Eur J Neurosci; 2009 Jul; 30(1):1-8. PubMed ID: 19508697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
